Keith Barclay
Directeur en chef des Investissements chez Elasmogen Ltd.
Profil
Keith Barclay currently works at Elasmogen Ltd., as Director & Investor Director and Business Growth Fund Ltd, as Principal from 2015.
Mr. Barclay received his graduate degree from the University of Aberdeen.
Postes actifs de Keith Barclay
| Sociétés | Poste | Début |
|---|---|---|
Business Growth Fund Ltd
 Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the UK. | Private Equity Investor | 01/11/2015 |
Elasmogen Ltd.
 Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Directeur en chef des Investissements | - |
Formation de Keith Barclay
| University of Aberdeen | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Business Growth Fund Ltd
Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the UK. | Finance |
Elasmogen Ltd.
Elasmogen Ltd. Pharmaceuticals: MajorHealth Technology Elasmogen Ltd. develops soloMER products for treatment of auto-immune mediated and inflammatory diseases. The company is headquartered in Aberdeen, the United Kingdom. | Health Technology |
